Anaplastic Thyroid Carcinoma and Toxic Multinodular Goiter: A Case Report and Literature Review
Judi Clinical Journal · 20.06.2026 · 2 (1) · 49-53
DOI: 10.70955/jcj.2026.07 ↗Kurz gefasst
Fallbericht in der Zeitschrift Judi Clinical Journal, online erschienen am 20.06.2026. Verfasst von Abdulwahid M. Salih und 8 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Anaplastic thyroid carcinoma (ATC) is a rare thyroid malignancy, comprising approximately 2% of all thyroid cancers, yet accounting for the majority of thyroid cancer-related deaths. ATC is characterized by aggressive behavior and rapid local invasion, leading to life-threatening complications such as airway compromise, dysphagia, and vascular encasement. Longstanding thyroid conditions such as multinodular goiter (MNG) may predispose to malignant transformation into ATC. We report a case of ATC arising in a patient with a decade-long history of toxic MNG, underscoring the potential for severe complications even in seemingly stable thyroid disease. Case presentation: A 68-year-old female with a 10-year history of toxic MNG presented with neck swelling, dyspnea, and dysphagia. Laboratory findings showed suppressed thyroid-stimulating hormone and elevated free T4. Ultrasonography revealed nodules with macrocalcifications. A total thyroidectomy was performed, and histopathological examination revealed ATC originating from one of the MNG nodules. Postoperatively, she received adjuvant chemoradiotherapy with carboplatin and doxorubicin. Initial imaging showed no metastasis, but after 10 months, a supraclavicular lymph node and posterior lung nodules indicated disease progression. She developed pneumonia during treatment, leading to its discontinuation. Despite restarting therapy, her condition worsened, and she passed away eight months later. Literature review: A literature review identified six reported cases of ATC arising from MNG published between 2001 and 2020. The duration of MNG before malignant transformation varied from years to decades.
Conclusion
Longstanding MNG may progress to malignancy over time. Early diagnosis and appropriate management of MNGs are critical to minimizing the risk of malignant transformation.
Introduction
Thyroid malignancy is the most common endocrine cancer, representing 2.1% of cases. Papillary thyroid carcinoma accounts for the majority at 80%, followed by follicular thyroid carcinoma (10%), medullary thyroid carcinoma (4%), oncocytic cell carcinoma (3%), and anaplastic thyroid carcinoma (ATC) (2%) [1]. Anaplastic thyroid carcinoma is among the most aggressive and deadly solid tumors in humans, with an incidence rate of 1–2 cases per million [2]. It has the worst prognosis among thyroid cancers, with an average survival period of 3–9 months and a 3-year overall survival rate of just 10% [3]. Clinically, ATC presents with rapid onset of compressive symptoms, including dyspnea, dysphagia, and hoarseness, and frequently progresses to local invasion and distant metastasis, posing significant life-threatening complications [4]. Pre-existing thyroid conditions, such as longstanding multinodular goiter (MNG) or well-differentiated thyroid malignancies, may act as risk factors for anaplastic transformation [5]. Multinodular goiter, currently classified in the WHO 2022 classification as thyroid follicular nodular disease, is an enlargement of the thyroid gland distinguished by the presence of discrete palpable nodules. It is more prevalent in mountainous areas, including Southeast Asia, Latin America, and Central Africa. Among thyroid cancers, papillary thyroid carcinoma is most frequently associated with MNG, followed by follicular carcinoma and anaplastic carcinoma [3]. The prevalence of thyroid malignancy in thyrotoxic conditions, particularly toxic MNG, remains a subject of debate. Reported rates of thyroid cancer in MNG range from 3% to 35%, whereas cases of ATC arising from long-standing toxic MNG are exceedingly rare [3,4,6,7]. Here, we present a case of ATC occurring in a patient with a 10-year history of toxic MNG. The report was prepared in accordance with the CaReL guidelines, and all references were assessed for eligibility and relevance [8,9]. Case presentation Patient information A 68-year-old female patient presented with anterior neck swelling for 10 years. She reported symptoms of dyspnea and dysphagia. She had a medical history of diabetes mellitus, hypertension, and anemia, but no history of prior surgeries. Clinical findings During the physical examination, the patient’s vital signs were stable. A large anterior neck swelling was observed on physical examination, with a firm consistency upon palpation. Diagnostic approach Routine thyroid function tests revealed a thyroid-stimulating hormone level of
Zitieren
APA
Salih, A. M., Ali, R. M., Ali, R. M., Ahmed, A. H., Hassan, S. H., Nasralla, H. A., Nasraldeen, S. A., Qadir, A. A., & Ahmed, H. A. (2026). Anaplastic Thyroid Carcinoma and Toxic Multinodular Goiter: A Case Report and Literature Review. Judi Clinical Journal, 2(1), 49-53. https://doi.org/10.70955/jcj.2026.07
Vancouver
Salih AM, Ali RM, Ali RM, Ahmed AH, Hassan SH, Nasralla HA, et al. Anaplastic Thyroid Carcinoma and Toxic Multinodular Goiter: A Case Report and Literature Review. Judi Clinical Journal. 2026;2(1):49-53. doi:10.70955/jcj.2026.07
BibTeX
@article{Salih2026,
author = {Salih, Abdulwahid M. and Ali, Rebaz M. and Ali, Rawa M. and Ahmed, Ahmed H. and Hassan, Shko H. and Nasralla, Hawkar A. and Nasraldeen, Shalaw A. and Qadir, Abdullah A. and Ahmed, Harun Amanj},
title = {Anaplastic Thyroid Carcinoma and Toxic Multinodular Goiter: A Case Report and Literature Review},
journal = {Judi Clinical Journal},
year = {2026},
volume = {2},
number = {1},
pages = {49--53},
doi = {10.70955/jcj.2026.07}
}
EUVIMED